glp-1 receptor agonist nausea diarrhea management glp-1_analogs [TUSOM Treatment of Bile Acid Diarrhea
Description
STAT: cAMP-PKA-signal transducers and activators of transcription
Indeed, a 2022 study found that after stopping a regimen of Semaglutide, the active ingredient in Ozempic, patients regained 2/3rds of the weight loss within one year
Document your current state
Conclusion Switching to injectable semaglutide from any other GLP-1 RA was associated with significant improvements in glycaemic control and weight
Yet subcutaneous injections of recombinant GLP-1 were a disappointment in patients, falling short of prior results with intravenous GLP-1
